Time to treat the climate and nature crisis as one indivisible global health emergency
Expert Rev Pharmacoecon Outcomes Res. 2023 Oct 30:1-3. doi: 10.1080/14737167.2023.2276519. Online ahead of print.NO ABSTRACTPMID:37902060 | DOI:10.1080/14737167.2023.2276519 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - October 30, 2023 Category: Health Management Authors: Kamran Abbasi Parveen Ali Virginia Barbour Thomas Benfield Kirsten Bibbins-Domingo Gregory E Erhabor Stephen Hancocks Richard Horton Laurie Laybourn-Langton Robert Mash Peush Sahni Wadeia Mohammad Sharief Paul Yonga Chris Zielinski Source Type: research

Seeing the whole elephant: integrated advanced data analytics in support of RWE for the development and use of innovative pharmaceuticals
Expert Rev Pharmacoecon Outcomes Res. 2023 Oct 30:1-6. doi: 10.1080/14737167.2023.2275674. Online ahead of print.ABSTRACTINTRODUCTION: The 21st century has brought about significant technological advancement, allowing the collection of new types of data from the real world on an unprecedented scale. The healthcare industry will benefit immensely from this abundance of patient data from electronic health records (EHR), patient-reported outcomes (PROs), laboratory, demographic, social media, digital, and even climate data.AREAS COVERED: While conventional statistical methods still play a significant role in supporting the dr...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - October 30, 2023 Category: Health Management Authors: Won Chan Lee Source Type: research

Time to treat the climate and nature crisis as one indivisible global health emergency
Expert Rev Pharmacoecon Outcomes Res. 2023 Oct 30:1-3. doi: 10.1080/14737167.2023.2276519. Online ahead of print.NO ABSTRACTPMID:37902060 | DOI:10.1080/14737167.2023.2276519 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - October 30, 2023 Category: Health Management Authors: Kamran Abbasi Parveen Ali Virginia Barbour Thomas Benfield Kirsten Bibbins-Domingo Gregory E Erhabor Stephen Hancocks Richard Horton Laurie Laybourn-Langton Robert Mash Peush Sahni Wadeia Mohammad Sharief Paul Yonga Chris Zielinski Source Type: research

Seeing the whole elephant: integrated advanced data analytics in support of RWE for the development and use of innovative pharmaceuticals
Expert Rev Pharmacoecon Outcomes Res. 2023 Oct 30:1-6. doi: 10.1080/14737167.2023.2275674. Online ahead of print.ABSTRACTINTRODUCTION: The 21st century has brought about significant technological advancement, allowing the collection of new types of data from the real world on an unprecedented scale. The healthcare industry will benefit immensely from this abundance of patient data from electronic health records (EHR), patient-reported outcomes (PROs), laboratory, demographic, social media, digital, and even climate data.AREAS COVERED: While conventional statistical methods still play a significant role in supporting the dr...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - October 30, 2023 Category: Health Management Authors: Won Chan Lee Source Type: research

Time to treat the climate and nature crisis as one indivisible global health emergency
Expert Rev Pharmacoecon Outcomes Res. 2023 Oct 30:1-3. doi: 10.1080/14737167.2023.2276519. Online ahead of print.NO ABSTRACTPMID:37902060 | DOI:10.1080/14737167.2023.2276519 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - October 30, 2023 Category: Health Management Authors: Kamran Abbasi Parveen Ali Virginia Barbour Thomas Benfield Kirsten Bibbins-Domingo Gregory E Erhabor Stephen Hancocks Richard Horton Laurie Laybourn-Langton Robert Mash Peush Sahni Wadeia Mohammad Sharief Paul Yonga Chris Zielinski Source Type: research

Seeing the whole elephant: integrated advanced data analytics in support of RWE for the development and use of innovative pharmaceuticals
Expert Rev Pharmacoecon Outcomes Res. 2023 Oct 30:1-6. doi: 10.1080/14737167.2023.2275674. Online ahead of print.ABSTRACTINTRODUCTION: The 21st century has brought about significant technological advancement, allowing the collection of new types of data from the real world on an unprecedented scale. The healthcare industry will benefit immensely from this abundance of patient data from electronic health records (EHR), patient-reported outcomes (PROs), laboratory, demographic, social media, digital, and even climate data.AREAS COVERED: While conventional statistical methods still play a significant role in supporting the dr...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - October 30, 2023 Category: Health Management Authors: Won Chan Lee Source Type: research

Time to treat the climate and nature crisis as one indivisible global health emergency
Expert Rev Pharmacoecon Outcomes Res. 2023 Oct 30:1-3. doi: 10.1080/14737167.2023.2276519. Online ahead of print.NO ABSTRACTPMID:37902060 | DOI:10.1080/14737167.2023.2276519 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - October 30, 2023 Category: Health Management Authors: Kamran Abbasi Parveen Ali Virginia Barbour Thomas Benfield Kirsten Bibbins-Domingo Gregory E Erhabor Stephen Hancocks Richard Horton Laurie Laybourn-Langton Robert Mash Peush Sahni Wadeia Mohammad Sharief Paul Yonga Chris Zielinski Source Type: research

Seeing the whole elephant: integrated advanced data analytics in support of RWE for the development and use of innovative pharmaceuticals
Expert Rev Pharmacoecon Outcomes Res. 2023 Oct 30:1-6. doi: 10.1080/14737167.2023.2275674. Online ahead of print.ABSTRACTINTRODUCTION: The 21st century has brought about significant technological advancement, allowing the collection of new types of data from the real world on an unprecedented scale. The healthcare industry will benefit immensely from this abundance of patient data from electronic health records (EHR), patient-reported outcomes (PROs), laboratory, demographic, social media, digital, and even climate data.AREAS COVERED: While conventional statistical methods still play a significant role in supporting the dr...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - October 30, 2023 Category: Health Management Authors: Won Chan Lee Source Type: research

Time to treat the climate and nature crisis as one indivisible global health emergency
Expert Rev Pharmacoecon Outcomes Res. 2023 Oct 30:1-3. doi: 10.1080/14737167.2023.2276519. Online ahead of print.NO ABSTRACTPMID:37902060 | DOI:10.1080/14737167.2023.2276519 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - October 30, 2023 Category: Health Management Authors: Kamran Abbasi Parveen Ali Virginia Barbour Thomas Benfield Kirsten Bibbins-Domingo Gregory E Erhabor Stephen Hancocks Richard Horton Laurie Laybourn-Langton Robert Mash Peush Sahni Wadeia Mohammad Sharief Paul Yonga Chris Zielinski Source Type: research

Seeing the whole elephant: integrated advanced data analytics in support of RWE for the development and use of innovative pharmaceuticals
Expert Rev Pharmacoecon Outcomes Res. 2023 Oct 30:1-6. doi: 10.1080/14737167.2023.2275674. Online ahead of print.ABSTRACTINTRODUCTION: The 21st century has brought about significant technological advancement, allowing the collection of new types of data from the real world on an unprecedented scale. The healthcare industry will benefit immensely from this abundance of patient data from electronic health records (EHR), patient-reported outcomes (PROs), laboratory, demographic, social media, digital, and even climate data.AREAS COVERED: While conventional statistical methods still play a significant role in supporting the dr...
Source: Expert Review of Pharmacoeconomics and Outcomes Research - October 30, 2023 Category: Health Management Authors: Won Chan Lee Source Type: research

Payer and Developer perspectives on alternative payment models
CONCLUSION: Although limited by the number of participants, this survey indicates early discussions coupled with understanding motivations are essential for developing contracts that appeal to both parties and ensure patient access.PMID:37883069 | DOI:10.1080/14737167.2023.2276374 (Source: Expert Review of Pharmacoeconomics and Outcomes Research)
Source: Expert Review of Pharmacoeconomics and Outcomes Research - October 26, 2023 Category: Health Management Authors: Renita Moradian Tsega Meshesha Mark Trusheim Jane F Barlow Source Type: research